What is Albendazole Suspension? An oral dose form in which the active drug, albendazole, is added to a liquid dosage form or suspension vehicle in a form that is suitable for suspension. As there are no details on strength and excipients, formulation development is based on the approved product specification rather than for a certain concentration or combination of ingredients. For your oral-liquid product list, Albendazole Suspension can be used as part of a well-organized PCD Pharma Franchise product portfolio.
Active Pharmaceutical Ingredient Physical Characterisation It is important to assess the physical characterisation of the active pharmaceutical ingredient (API) to ensure the right formulation is developed. Albendazole Dispersion and Suspension - Particle dispersion, suspension stability are major considerations in the formulation development.
They may also include other excipients such as appropriate suspending agents, wetting agents, viscosity modifiers, sweetening agents, flavours, preservatives (where necessary) or others as approved. The choice of these excipients is determined by the physical characters of the finished formulation.
[00028] Particle size distribution: It can affect sedimentation behaviour, redispersability, viscosity and appearance. Appropriate milling processes or methods of particle processing might be considered during formulation development in order to optimise these properties.
Wetting of the particles of ALB. Proper wetting of the particles of albendazole is an important step in the production of a homogenous suspension. Inadequate wetting leads to floating, caking and erratic dispersement of particles in the vehicle.
For the manufacturing process, the active ingredient can be pre-dispersed in a controlled manner and can be slowly dispersed into the preformed vehicle. Aspects like mixing speed, time, temperature and processing sequence can be designed on formulation technology basis.
Proper homogenization should be achieved in order to uniformly disperse the suspended particles through the bulk of the liquid. The resulting suspension should be characterized by stable physical properties without being overly dispersed or phase separated.
Dissolution rate directly affects the rheological behaviour of Albendazole Suspension, sedimentation, filling, pouring and dose-volume consistency. A proper viscosity profile is assumed to help with the suspension of the substance while making it easy to pour out of the package.
Re-dispersibility is a further critical aspects to product development, as what may settle in a suspension can happen during storage; formulation should be tested for re-dispersing with the right amount of shaking depending on the product design.
Physicial assessment: Appearance, colour, odour, pH, viscosit, sedimentation behaviour, particle distribution and redmesibility must be checked. They should be within the parameters of the product specifications for the required period of storage.
Manufacture of the product is commenced with the importation of appropriate raw materials and the formulation of the liquid vehicle according to the written batch formula. The active is added under controlled mixing to generate a homogenous bulk suspension.
In-process inspection may encompass bulk appearance, pH, viscosity, homogeneity and other formulation-dependent factors. Representative sampling is critical, as a suspension needs to be adequately stable when bulk processed and filled.
Finished-product testing may comprise identification and assay of albendazole, pH, viscosity, microbial quality, fill volume, dispersibility, and others where relevant. Analytical procedures should be suitably validated or qualified.
Stability testing. He stability studies help determine if Albendazole Suspension retains its physical, chemical, and microbiological properties during the shelf life. For example: the following can be monitored: assay, appearance, colour, pH, viscosity, sedimentation, re-dispersibility, microbial quality, etc.
The choice of packaging should be made in relation to the stability requirements of the formulation. Suitable pharmaceutical-grade bottles with closure may be assessed for leach resistance, container–closure integrity, ease of dispensing and compatibility with the suspension.
Handling and product presentation (including headspace and bottle design) may affect the manner in which the product is handled. Proper secondary packaging and labelling will also assist shipment and contribute to batch identification.
Albendazole Suspension demands close interaction between the particle engineering, vehicle choice, wetting, viscosity modification, homogenization and stability testing of the final product. As the composition and excipient system specified dictates the performance of the final formulation, product development should only be performed on the approved composition and manufacturing specification.
For pharma companies with a wider PCD Pharma Franchise range. This oral suspension can also be used in a class range of liquid products with specific raw-material parameters, standardized processing, analytical testing, and packaging.
API characterization and particle preparation Vehicle development Controlled dispersion Bulk testing Filling and stability monitoring Each step has an important role to play in achieving consistent product quality. A formulation-specific manufacturing process supports consistency, dispersibility, and the physical and chemical profile of Albendazole Suspension over its designated shelf life.
Albendazole Suspension formulation, suspension stability, manufacturing, quality control, packaging and product development details for pharma companies.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech